OXFORD BIODYNAMICS PLC (LON:OBD)
SECTOR – HEALTHCARE
MARKET CAP – £171m
CURRENT PRICE – 199p
US patent granted for EpiSwitch™
NORTHLAND VIEW
Oxford BioDynamics announced the approval of a US patent regarding the Company’s EpiSwitch™ drug discovery platform.
The patent (No. 9777327) covers technology designs for the discovery and monitoring of chromosomal conformation signatures used in the EpiSwitch™ platform.
Chromosomal confirmation signatures can act as biomarkers, which can be used to stratify different patient phenotypes. The EpiSwitch™ platform allows for improved identification of potential drug targets and de-risking of the drug discovery and development pathway.
The patent extends the coverage of the EpiSwitch™ IP estate into the US. Counterparts to this patent have been granted in Europe, China, Japan, Australia, Hong Kong, New Zealand, Singapore and South Africa.
The granting of this patent extends the IP estate of EpiSwitch™, Oxford Biodynamics’ proprietary technology, into the US, a key market for the Company. Having previously received analogous patents in other regions, including Asia and Europe, Oxford Biodynamics has generated a strong global IP estate surrounding its proprietary technology.
COMPANY DESCRIPTION
Oxford BioDynamics is a clinical stage biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture for use within the pharmaceutical and biotechnology industry.
SAVANNAH RESOURCES (LON:SAV)
SECTOR – MINING
RATING – CORP*
MARKET CAP – £33m
CURRENT PRICE – 5.9p#
From yesterday: Omani copper project update
NORTHLAND VIEW
Savannah Resources has received regulatory approval or “No Objection” from six Ministries for the Maqail South License application and four for the Mahab 4 License application, to date.
It has also completed the hydrological baseline assessment for the proposed tailings storage facility and commenced the environmental impact assessment for the tailings storage facility and processing plant.
The scoping study for the project is nearing completion.
The Company is targeting H118 for production.
Savannah Resources is making rapid progress in gaining approvals for its Omani Copper Project, completion of the permitting will be a major milestone for the Company. Another major milestone expected in the near-term is the completion of the scoping study which will give us a better idea of the projects metrics and potential returns.
COMPANY DESCRIPTION
Savannah Resources is an exploration and development company with copper-gold projects located in Oman, a mineral sands project in Mozambique and lithium projects in Finland and Portugal.
PREMIER AFRICAN MINERALS (LON:PREM)
SECTOR – MINING
RATING – CORP*
MARKET CAP – £15.4m
CURRENT PRICE – 0.28p
From yesterday: raises £3.5m to repay loan and reduce swap agreement
NORTHLAND VIEW
Premier African Minerals has raised £3.5m through the issue of 654,761,906 shares at a price 0.3p per share, to repay a loan note and reduce a swap agreement.
The shares already issued in regard to the swap agreement will be repurchased by the Company and reissued to subscribers.
Following the issue of the shares, the Company will have 6,248,216,350 ordinary shares in issue.
Positive news for Premier African Minerals with the proceeds of this placing repaying the loan note and reducing the swap agreement. The underground development of the RHA Tungsten Mine is now fully funded and the Company is confident that the minimum required tonnage and grade will be delivered to the plant during the latter part of Q417, ensuring profitable operations. Prem does not now expect any further capital raise for RHA.
COMPANY DESCRIPTION
Premier African Minerals is a multi-commodity exploration and development company with assets located across Africa. Its principal asset is a 49% operator interest in the RHA Tungsten Mine located in Zimbabwe. It has also recently acquired a Limestone and Forestry business located in Mozambique.